Who are Glycerine's main competitors?

Direct comparators (same drug class / molecular target / therapeutic area): Naphcon Forte, Hemorrhoid, Fissure, ProctalgiaSuppositories, mouth spray, Carboxymethylcellulose sodium and Glycerin, Ferulic Acid, Goat Milk.

How often does this brief refresh?

Every 30 minutes from primary sources (FDA, EMA, MHRA, PMDA, ClinicalTrials.gov, USPTO). Subscribe to the RSS feed below for push alerts.

How do I get this as a recurring report?

Subscribe to /feed/ci/glycerine.xml in any RSS reader (Feedly, Inoreader, NewsBlur). Every regulatory action, trial readout, or patent event lands in your feed automatically.

Last reviewed 2026-05-14 · How we verify

Glycerine — Competitive Intelligence Brief

Glycerine (Glycerine) competitive landscape: 6 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Non-Standardized Chemical Allergen [EPC]. Area: Metabolic.

marketed Non-Standardized Chemical Allergen [EPC] Metabolic Small molecule Live · refreshed every 30 min

Target snapshot

Glycerine (Glycerine) — Ferring Pharmaceuticals.

Comparator set (6 drugs)

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

Drug	Generic	Sponsor	Phase	Class	Target	Approval / PDUFA
Glycerine TARGET	Glycerine	Ferring Pharmaceuticals	marketed	Non-Standardized Chemical Allergen [EPC]
Naphcon Forte	NAPHAZOLINE	Novartis	marketed	Non-Standardized Chemical Allergen [EPC]	Alpha-2A adrenergic receptor	1971-01-01
Hemorrhoid, Fissure, ProctalgiaSuppositories	BORNEOL	WU XI ZHONG ZHI WEI NA TECHNOLOGY CO., Ltd.	marketed	Non-Standardized Chemical Allergen [EPC]
mouth spray	mouth spray	University of Oklahoma	marketed	Non-Standardized Chemical Allergen [EPC]
Carboxymethylcellulose sodium and Glycerin	Carboxymethylcellulose sodium and Glycerin	Allergan	marketed	Non-Standardized Chemical Allergen [EPC]
Ferulic Acid	Ferulic Acid	Salah Awad Alanazi	marketed	Non-Standardized Chemical Allergen [EPC]
Goat Milk	Goat Milk	City of Hope Medical Center	marketed	Non-Standardized Chemical Allergen [EPC]

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Non-Standardized Chemical Allergen [EPC] class)

Allergan · 1 drug in this class
City of Hope Medical Center · 1 drug in this class
Ferring Pharmaceuticals · 1 drug in this class
Novartis · 1 drug in this class
Salah Awad Alanazi · 1 drug in this class
University of Oklahoma · 1 drug in this class
WU XI ZHONG ZHI WEI NA TECHNOLOGY CO., Ltd. · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Glycerine — Competitive Intelligence Brief. https://druglandscape.com/ci/glycerine. Accessed 2026-05-14.

Build your own brief

Pick any drug + add comparators:

https://druglandscape.com/ci/{slug} — auto-detected competitors
https://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3 — explicit comparators
Brand names auto-resolve: /ci/keytruda → 301 → /ci/pembrolizumab